Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T25889 | ||||
Target Name | Adenylate cyclase (ADCY) | ||||
Type of Target |
Literature-reported |
||||
Drug Potency against Target | 2,5-didesoxy-3-ATP | Drug Info | IC50 = 700 nM | [3] | |
2-hydroxy-17beta-estradiol | Drug Info | IC50 = 3000 nM | [3] | ||
DEOXYADENOSINE | Drug Info | IC50 = 15000 nM | [1] | ||
N6-CYCLOPENTYLADENOSINE | Drug Info | IC50 = 3200 nM | [2] | ||
NSC-270718 | Drug Info | IC50 = 11000 nM | [3] | ||
NSC-88915 | Drug Info | IC50 = 1100 nM | [3] | ||
References | |||||
REF 1 | Synthesis of 2',5'-dideoxy-2-fluoroadenosine and 2',5'-dideoxy-2,5'-difluoroadenosine: potent P-site inhibitors of adenylyl cyclase. J Med Chem. 2004 Feb 26;47(5):1207-13. | ||||
REF 2 | Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors. J Med Chem. 1991 Dec;34(12):3388-90. | ||||
REF 3 | Structure-based development of novel adenylyl cyclase inhibitors. J Med Chem. 2008 Aug 14;51(15):4456-64. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.